Literature DB >> 19429924

Natural ligands for CD33-related Siglecs?

Ajit Varki1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19429924      PMCID： PMC2704899          DOI： 10.1093/glycob/cwp063

Source DB:  PubMed          Journal:  Glycobiology        ISSN： 0959-6658            Impact factor:   4.313


× No keyword cloud information.
  30 in total

1.  The acute-phase protein alpha 1-acid glycoprotein (AGP) induces rises in cytosolic Ca2+ in neutrophil granulocytes via sialic acid binding immunoglobulin-like lectins (siglecs).

Authors:  Peter Gunnarsson; Louise Levander; Peter Påhlsson; Magnus Grenegård
Journal:  FASEB J       Date:  2007-08-03       Impact factor: 5.191

2.  Defining the in vivo function of Siglec-F, a CD33-related Siglec expressed on mouse eosinophils.

Authors:  Mai Zhang; Takashi Angata; Jae Youn Cho; Marina Miller; David H Broide; Ajit Varki
Journal:  Blood       Date:  2007-02-01       Impact factor: 22.113

3.  Siglec-H is an IPC-specific receptor that modulates type I IFN secretion through DAP12.

Authors:  Amanda L Blasius; Marina Cella; Jorge Maldonado; Toshiyuki Takai; Marco Colonna
Journal:  Blood       Date:  2005-11-17       Impact factor: 22.113

4.  Discovery of Siglec-14, a novel sialic acid receptor undergoing concerted evolution with Siglec-5 in primates.

Authors:  Takashi Angata; Toshiyuki Hayakawa; Masahiro Yamanaka; Ajit Varki; Mitsuru Nakamura
Journal:  FASEB J       Date:  2006-10       Impact factor: 5.191

Review 5.  Siglecs and their roles in the immune system.

Authors:  Paul R Crocker; James C Paulson; Ajit Varki
Journal:  Nat Rev Immunol       Date:  2007-04       Impact factor: 53.106

6.  SIGLEC16 encodes a DAP12-associated receptor expressed in macrophages that evolved from its inhibitory counterpart SIGLEC11 and has functional and non-functional alleles in humans.

Authors:  Huan Cao; Ursula Lakner; Bernard de Bono; James A Traherne; John Trowsdale; Alexander D Barrow
Journal:  Eur J Immunol       Date:  2008-08       Impact factor: 5.532

7.  Human B-lymphocytes express alpha2-6-sialylated 6-sulfo-N-acetyllactosamine serving as a preferred ligand for CD22/Siglec-2.

Authors:  Naoko Kimura; Katsuyuki Ohmori; Keiko Miyazaki; Mineko Izawa; Yuji Matsuzaki; Yosuke Yasuda; Hiromu Takematsu; Yasunori Kozutsumi; Akihiko Moriyama; Reiji Kannagi
Journal:  J Biol Chem       Date:  2007-08-28       Impact factor: 5.157

Review 8.  Myelin-associated glycoprotein binding to gangliosides. Structural specificity and functional implications.

Authors:  R L Schnaar; B E Collins; L P Wright; M Kiso; M B Tropak; J C Roder; P R Crocker
Journal:  Ann N Y Acad Sci       Date:  1998-06-19       Impact factor: 5.691

Review 9.  You say ITAM and I say ITIM, let's call the whole thing off: the ambiguity of immunoreceptor signalling.

Authors:  Alexander David Barrow; John Trowsdale
Journal:  Eur J Immunol       Date:  2006-07       Impact factor: 5.532

10.  Identification of CD22 ligands on bone marrow sinusoidal endothelium implicated in CD22-dependent homing of recirculating B cells.

Authors:  L Nitschke; H Floyd; D J Ferguson; P R Crocker
Journal:  J Exp Med       Date:  1999-05-03       Impact factor: 14.307
View more
  15 in total

Review 1.  Multifarious roles of sialic acids in immunity.

Authors:  Ajit Varki; Pascal Gagneux
Journal:  Ann N Y Acad Sci       Date:  2012-04       Impact factor: 5.691

Review 2.  Siglecs as sensors of self in innate and adaptive immune responses.

Authors:  James C Paulson; Matthew S Macauley; Norihito Kawasaki
Journal:  Ann N Y Acad Sci       Date:  2012-01-30       Impact factor: 5.691

3.  Since there are PAMPs and DAMPs, there must be SAMPs? Glycan “self-associated molecular patterns” dampen innate immunity, but pathogens can mimic them.

Authors:  Ajit Varki
Journal:  Glycobiology       Date:  2011-09       Impact factor: 4.313

4.  Factor VIII and von Willebrand factor are ligands for the carbohydrate-receptor Siglec-5.

Authors:  Julie N Pegon; Mohamad Kurdi; Caterina Casari; Soline Odouard; Cécile V Denis; Olivier D Christophe; Peter J Lenting
Journal:  Haematologica       Date:  2012-06-24       Impact factor: 9.941

Review 5.  Siglec-8 as a drugable target to treat eosinophil and mast cell-associated conditions.

Authors:  Takumi Kiwamoto; Norihito Kawasaki; James C Paulson; Bruce S Bochner
Journal:  Pharmacol Ther       Date:  2012-06-27       Impact factor: 12.310

Review 6.  The Neuro-Immune-Regulators (NIREGs) Promote Tissue Resilience; a Vital Component of the Host's Defense Strategy against Neuroinflammation.

Authors:  Yosra Bedoui; Jim W Neal; Philippe Gasque
Journal:  J Neuroimmune Pharmacol       Date:  2018-06-16       Impact factor: 4.147

7.  Microglial immunoreceptor tyrosine-based activation and inhibition motif signaling in neuroinflammation.

Authors:  Bettina Linnartz; Yiner Wang; Harald Neumann
Journal:  Int J Alzheimers Dis       Date:  2010-06-22

8.  T cell regulation mediated by interaction of soluble CD52 with the inhibitory receptor Siglec-10.

Authors:  Esther Bandala-Sanchez; Yuxia Zhang; Simone Reinwald; James A Dromey; Bo-Han Lee; Junyan Qian; Ralph M Böhmer; Leonard C Harrison
Journal:  Nat Immunol       Date:  2013-05-19       Impact factor: 25.606

Review 9.  Glycosynaptic microdomains controlling tumor cell phenotype through alteration of cell growth, adhesion, and motility.

Authors:  Sen-itiroh Hakomori
Journal:  FEBS Lett       Date:  2009-10-27       Impact factor: 4.124

10.  Soluble Siglec-5 associates to PSGL-1 and displays anti-inflammatory activity.

Authors:  Marion Pepin; Soraya Mezouar; Julie Pegon; Vincent Muczynski; Frédéric Adam; Elsa P Bianchini; Amine Bazaa; Valerie Proulle; Alain Rupin; Jerome Paysant; Laurence Panicot-Dubois; Olivier D Christophe; Christophe Dubois; Peter J Lenting; Cécile V Denis
Journal:  Sci Rep       Date:  2016-11-28       Impact factor: 4.379
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.